Home/S. M. Discovery Group (SMDG)/Dr. Farhangrazi

DF

Dr. Farhangrazi

CEO

S. M. Discovery Group (SMDG)

Therapeutic Areas

Neurodegenerative Diseases Rare Pediatric Diseases Immune Disorders Inflammatory Disorders

S. M. Discovery Group (SMDG) Pipeline

Drug	Indication	Phase
Platform-derived Programs	Neurodegenerative Diseases, Pediatric Neurological Disorders, Immune/Inflammatory Disorders	Pre-clinical

Leadership Team at S. M. Discovery Group (SMDG)

Professor Moein Moghimi

Chief Scientist, Platform Inventor

Dr. Christy Hunter

View full S. M. Discovery Group (SMDG) profile